Seronegative Epstein-Barr virus myeloradiculitis in an immunocompetent 72-year-old woman.
Mühlau
M
M
Department of Neurology, Technische Universität München, Germany. m.muehlau@neuro.med.tu-muenchen.de
Bülow
S
S
Stimmer
H
H
Schätzl
H
H
Berthele
A
A
D000212:Acyclovir / Q000627:therapeutic use; D000368:Aged; D000667:Ampicillin / Q000009:adverse effects / Q000627:therapeutic use; D000900:Anti-Bacterial Agents; D000956:Antigens, Viral / Q000097:blood; D002443:Ceftriaxone / Q000627:therapeutic use; D020031:Epstein-Barr Virus Infections / Q000150:complications*; D005260:Female; D004854:Herpesvirus 4, Human / Q000276:immunology; D006801:Humans; D007121:Immunocompetence / Q000276:immunology; D008159:Lumbar Vertebrae; D008279:Magnetic Resonance Imaging; D009187:Myelitis / Q000175:diagnosis / Q000503:physiopathology / Q000821:virology*; D010264:Paraplegia / Q000175:diagnosis / Q000503:physiopathology / Q000821:virology; D011843:Radiculopathy / Q000175:diagnosis / Q000503:physiopathology / Q000821:virology*; D013116:Spinal Cord / Q000473:pathology* / Q000503:physiopathology / Q000821:virology; D013126:Spinal Nerve Roots / Q000473:pathology* / Q000503:physiopathology / Q000821:virology; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000956:Antigens, Viral; D002443:Ceftriaxone; D000667:Ampicillin; D000212:Acyclovir